Biosimilars Commercialisation Summit 2019 Agenda

Welcome to Biosimilars Commercialisation Summit 2019!

The inaugural Biosimilars Commercialisation Summit is the only forum to dive deep into perfectin your market access strategy on a global level. Over 3 days of expert case-study presentations and interactive sessions this forum will help you to tailor your commercial strategy to penetrate both established and emerging markets. Taking into consideration global regulations and healthcare systems, methods to boost stakeholder confidence and pricing, this summit will give you the tools to ensure your biosimilar survives in this fierce market.

Download your copy of the agenda on the right >>

Join us in May to:

• Exploit opportunities to broaden patient access by hearing insight from Sandoz and Gedeon Ritcher on how to break into new and emerging markets, with huge scope for economic growth
• Learn from the experts by hearing panel discussions with Fresenius Kabi, NICE and the NHS to overcome the lack of confidence at each level, in an effort to battle misinformation and ensure a complete, end-to-end strategy
• Gain a comprehensive knowledge of global healthcare systems and regulatory affairs, giving you the tools to develop a bulletproof and international commercial strategy
• Understand how both Big Pharma and SMEs successfully launched biosimilars into the European Market in 2019 and avoided competition
• Start off on the right foot by appreciating the importance of incorporating the supply chain and manufacturing functions into your market access strategy

Don't like filling out forms? Email us at enquire@iqpc.co.uk and we'll send you a copy of the latest agenda.